Theolytics
UK - Oxford
BiotechnologyFocus: Oncolytic Adenovirus Therapies
Theolytics is a life sciences company focused on Oncolytic Adenovirus Therapies.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
THEO-260
Ovarian CancerClinical Trials (1)
NCT07211659Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
Phase 1THEO-260
Ovarian CancerClinical Trials (1)
NCT06618235Trial of THEO-260 in Ovarian Cancer Patients
Phase 1/2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2000
Portfolio: 2 clinical trials
Top TAs: Oncology
Publications: 5 in PubMed